Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study.

ABSTRACT:

SUBMITTER: Yang W 

PROVIDER: S-EPMC12613543 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature